The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Mammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.012 · Cited by 1,406
Schinkel, A. H., Wagenaar, E., Mol, C. A., & van Deemter, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118699 · Cited by 1,264
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
P-glycoprotein: from genomics to mechanism
Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., & Gottesman, M. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206948 · Cited by 1,074
Multiple molecular mechanisms for multidrug resistance transporters
Higgins, C. F. (2007) · Nature · doi:10.1038/nature05630 · Cited by 860
Leier, I., Jedlitschky, G., Buchholz, U., Cole, S. P., Deeley, R. G., & Keppler, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46856-1 · Cited by 853
Allen, J. D., van Loevezijn, A., Rademaker-Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H. M., Koomen, G., & Schinkel, A. H. (2002) · PubMed · Cited by 814
Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans
Palm, K., Stenberg, P., Luthman, K., & Artursson1, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012188625088 · Cited by 756
Self-citationHewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery
Polli, J. W., Wring, S. A., Humphreys, J. E., Huang, L., Morgan, J. B., Webster, L. O., & Serabjit-Singh, C. S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29270-3 · Cited by 662
Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
Self-citationThe Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity
Glavinas, H., Krajcsi, P., Cserepes, J., & Sarkadi, B. (2004) · Current Drug Delivery · doi:10.2174/1567201043480036 · Cited by 558
A general pattern for substrate recognition by P‐glycoprotein
Seelig, A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510252.x · Cited by 527
Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6
Cui, Y., König, J., Leier, I., Buchholz, U., & Keppler, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004968200 · Cited by 515
Positively Cooperative Sites for Drug Transport by P‐Glycoprotein with Distinct Drug Specificities
Shapiro, A. B., & Ling, V. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00130.x · Cited by 475
Ambient Occlusion and Edge Cueing for Enhancing Real Time Molecular Visualization
Tarini, M., Cignoni, P., & Montani, C. (2006) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2006.115 · Cited by 404
Gekeler, V., Ise, W., Sanders, K. H., Ulrich, W. R., & Beck, J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1344 · Cited by 396
Conseil, G., Baubichon-Cortay, H., Dayan, G., Jault, J.-M., Barron, D., & Di Pietro, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9831 · Cited by 381
ROLE OF ABCG2/BCRP IN BIOLOGY AND MEDICINE
Krishnamurthy, P., & Schuetz, J. D. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141238 · Cited by 356
Breedveld, P., Pluim, D., Cipriani, G., Wielinga, P., van Tellingen, O., Schinkel, A. H., & Schellens, J. H. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2416 · Cited by 351
ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics
Suzuki, M., Suzuki, H., Sugimoto, Y., & Sugiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212399200 · Cited by 341
ABC of oral bioavailability: transporters as gatekeepers in the gut
Dietrich, C. G., Geier, A., & Oude Elferink, R. P. J. (2003) · Gut · doi:10.1136/gut.52.12.1788 · Cited by 317
Rabindran, S. K., He, H., Singh, M. S., Brown, E., Collins, K., Annable, T., & Greenberger, L. M. (1998) · PubMed · Cited by 305
Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR
de Bruin, M., Miyake, K., Litman, T., Robey, R., & Bates, S. E. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00182-2 · Cited by 298
Structure–activity relationship of P-glycoprotein substrates and modifiers
Seelig, A., & Landwojtowicz, E. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00177-9 · Cited by 275
Stoichiometry and Physical Chemistry of Promiscuous Aggregate-Based Inhibitors
Coan, K. E. D., & Shoichet, B. K. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802977h · Cited by 225
Hunter, J., Hirst, B. H., & Simmons, N. L. (1993) · Pharmaceutical Research · doi:10.1023/a:1018972102702 · Cited by 223
The power of the pump: Mechanisms of action of P-glycoprotein (ABCB1)
Ambudkar, S. V., Kim, I.-W., & Sauna, Z. E. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.10.010 · Cited by 217
Gupta, A., Zhang, Y., Unadkat, J. D., & Mao, Q. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.065342 · Cited by 216
Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.
Volk, E. L., & Schneider, E. (2003) · PubMed · Cited by 215
Zelcer, N., Huisman, M. T., Reid, G., Wielinga, P., Breedveld, P., Kuil, A., Knipscheer, P., Schellens, J. H. M., Schinkel, A. H., & Borst, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303504200 · Cited by 200
Comparative Studies on in Vitro Methods for Evaluating in Vivo Function of MDR1 P-Glycoprotein
Adachi, Y., Suzuki, H., & Sugiyama, Y. (2001) · Pharmaceutical Research · doi:10.1023/a:1013358126640 · Cited by 195
Ekins, S., Kim, R. B., Leake, B. F., Dantzig, A. H., Schuetz, E. G., Lan, L.-B., Yasuda, K., Shepard, R. L., Winter, M. A., Schuetz, J. D., et al. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12192-x · Cited by 191
Ahlin, G., Karlsson, J., Pedersen, J. M., Gustavsson, L., Larsson, R., Matsson, P., Norinder, U., Bergström, C. A. S., & Artursson, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8003152 · Cited by 190
Self-citationPortrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1)
Bakos, É., & Homolya, L. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0160-8 · Cited by 177
A Computational Ensemble Pharmacophore Model for Identifying Substrates of P-Glycoprotein
Penzotti, J. E., Lamb, M. L., Evensen, E., & Grootenhuis, P. D. J. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255062 · Cited by 177
Huang, L., Wang, Y., & Grimm, S. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007534 · Cited by 169
Role Reversal for Anticancer Agents
Pardee, A. B. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.4.22 · Cited by 165
Three-dimensional Structure of P-glycoprotein
Rosenberg, M. F., Callaghan, R., Modok, S., Higgins, C. F., & Ford, R. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410296200 · Cited by 163
Isolation and Culture of Primary Human Hepatocytes
LeCluyse, E. L., Alexandre, E., Hamilton, G. A., Viollon‐Abadie, C., Coon, D. J., Jolley, S. L., & Richert, L. (2004) · Humana Press eBooks · doi:10.1385/1-59259-838-2:207 · Cited by 157
Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2
McDevitt, C. A., Collins, R. F., Conway, M. A., Modok, S., Storm, J., Kerr, I. D., Ford, R. C., & Callaghan, R. (2006) · Structure · doi:10.1016/j.str.2006.08.014 · Cited by 155
Exploring the Role of Different Drug Transport Routes in Permeability Screening
Matsson, P., Bergström, C. A. S., Nagahara, N., Tavelin, S., Norinder, U., & Artursson, P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049711o · Cited by 147
Self-citationMatsson, P., Englund, G., Ahlin, G., Bergström, C. A. S., Norinder, U., & Artursson, P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124768 · Cited by 143
Self-citationPedersen, J. M., Matsson, P., Bergström, C. A. S., Norinder, U., Hoogstraate, J. A., & Artursson, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7015683 · Cited by 131
Self-citationThe Role of Half-Transporters in Multidrug Resistance
Bates, S. E., Robey, R. W., Miyake, K., Rao, K. V., Ross, D. D., & Litman, T. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012879205914 · Cited by 130
Computational Models for Identifying Potential P-Glycoprotein Substrates and Inhibitors
Crivori, P., Reinach, B., Pezzetta, D., & Poggesi, I. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050071a · Cited by 128
Pleban, K., Kopp, S., Csaszar, E., Peer, M., Hrebicek, T., Rizzi, A. M., Ecker, G. F., & Chiba, P. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006973 · Cited by 122
Moran, O., Galietta, L., & Zegarra-Moran, O. (2005) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-004-4422-3 · Cited by 120
Smitherman, P. K., Townsend, A. J., Kute, T. E., & Morrow, C. S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.057729 · Cited by 113
Quantification and Characterization of P-Glycoprotein−Substrate Interactions
Gatlik-Landwojtowicz, E., Äänismaa, P., & Seelig, A. (2006) · Biochemistry · doi:10.1021/bi051380+ · Cited by 111
Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes
Bow, D. A. J., Perry, J. L., Miller, D. S., Pritchard, J. B., & Brouwer, K. L. R. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018200 · Cited by 109
MRP2 and 3 in health and disease
Borst, P., Zelcer, N., & van de Wetering, K. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.05.051 · Cited by 107
Perfusion studies of glyburide transfer across the human placenta: Implications for fetal safety
Kraemer, J. M., Klein, J., Lubetsky, A., & Koren, G. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.12.005 · Cited by 107
Sakurai, A., Onishi, Y., Hirano, H., Seigneuret, M., Obanayama, K., Kim, G., Liew, E. L., Sakaeda, T., Yoshiura, K.-I., Niikawa, N., et al. (2007) · Biochemistry · doi:10.1021/bi700330b · Cited by 103
Global and Local Computational Models for Aqueous Solubility Prediction of Drug-Like Molecules
Bergström, C. A. S., Wassvik, C. M., Norinder, U., Luthman, K., & Artursson, P. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci049909h · Cited by 100
Self-citationSasaki, M., Suzuki, H., Aoki, J., Ito, K., Meier, P. J., & Sugiyama, Y. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05627-x · Cited by 96
Ramaen, O., Leulliot, N., Sizun, C., Ulryck, N., Pamlard, O., Lallemand, J., TILBEURGH, H. V., & Jacquet, E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.04.005 · Cited by 93
Drug metabolite profiling and elucidation of drug-induced hepatotoxicity
Tang, W. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.3.407 · Cited by 90
Oloo, E. O., & Tieleman, D. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405084200 · Cited by 89
Janneh, O., Owen, A., Chandler, B., Hartkoorn, R. C., Hart, C. A., Bray, P. G., Ward, S. A., Back, D. J., & Khoo, S. (2005) · AIDS · doi:10.1097/01.aids.0000194793.36175.40 · Cited by 88
Omote, H., & Al‐Shawi, M. K. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.077743 · Cited by 87
Sasaki, K., Makita, N., Sunami, A., Sakurada, H., Shirai, N., Yokoi, H., Kimura, A., Tohse, N., Hiraoka, M., & Kitabatake, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.2.330 · Cited by 74
Taipalensuu, J., Tavelin, S., Lazorova, L., Svensson, A.-C., & Artursson, P. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00204-5 · Cited by 71
Self-citationPezza, R. J., Villarreal, M. A., Montich, G. G., & Argaraña, C. E. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf606 · Cited by 70
New light on multidrug binding by an ATP-binding-cassette transporter
Shilling, R. A., Venter, H., Velamakanni, S., Bapna, A., Woebking, B., Shahi, S., & van Veen, H. W. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.02.008 · Cited by 66
Influence of P‐Glycoprotein on the Transplacental Passage of Cyclosporine
Pávek, P., Fendrich, Z., Štaud, F., Maláková, J., Brozmanová, H., Lázníček, M., Semecký, V., Grundmann, M., & Palička, V. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1108 · Cited by 65
Sauna, Z. E., Andrus, M. B., Turner, T. M., & Ambudkar, S. V. (2004) · Biochemistry · doi:10.1021/bi035965k · Cited by 64
Harris, M. J., Kuwano, M., Webb, M., & Philip G. Board (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010566200 · Cited by 61
Englund, G., Hallberg, P., Artursson, P., et al. (2004) · BMC Medicine · doi:10.1186/1741-7015-2-8 · Cited by 60
Self-citationOzawa, N., Shimizu, T., Morita, R., Yokono, Y., Ochiai, T., Munesada, K., Ōhashi, A., Aida, Y., Hama, Y., Taki, K., et al. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000048207.11160.d0 · Cited by 59
Roles of P-Glycoprotein, Bcrp, and Mrp2 in Biliary Excretion of Spiramycin in Mice
Tian, X., Li, J., Zamek‐Gliszczynski, M. J., Bridges, A. S., Zhang, P., Patel, N. J., Raub, T. J., Pollack, G. M., & Brouwer, K. L. R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00082-07 · Cited by 32
Létourneau, I. J., Slot, A. J., Deeley, R. G., & Cole, S. P. C. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015479 · Cited by 23
Cited by
Coexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
Self-citationKarlgren, M., Vildhede, A., Norinder, U., Wisniewski, J. R., Kimoto, E., Lai, Y., Haglund, U., & Artursson, P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300212s · Cited by 369
Self-citationPredicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)
Varma, M. V., Steyn, S. J., Allerton, C., & El-Kattan, A. F. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1749-4 · Cited by 334
Extra-Renal Elimination of Uric Acid via Intestinal Efflux Transporter BCRP/ABCG2
Hosomi, A., Nakanishi, T., Fujita, T., & Tamai, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030456 · Cited by 258
Prediction of drug–ABC-transporter interaction — Recent advances and future challenges
Montanari, F., & Ecker, G. F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.001 · Cited by 257
Metadata
- Authors
- Matsson, P., Pedersen, J. M., Norinder, U., Bergström, C. A. S., & Artursson, P.
- Venue
- Pharmaceutical Research
- Published
- 2009-05-07
- Volume
- 26
- Issue
- 8
- Pages
- 1816-1831
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2084769078
- Cited by
- 316
- References
- 75
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.